Arena Life Science


  • Generic name: Ranolazine

  • Pharmacologic Category: Anti-anginal

  • Dosage Forms: 500 mg extended-release tablet

  • Mechanism of Action: A direct, selective inhibitor of Factor Xa 

  • Treatment of chronic/refractory angina with no effect on heart rate and blood pressure.


Ranolazine acts by inhibiting the cardiac late sodium current (INa) and
hence prevents sodium dependent calcium accumulation in the cell.

It is important to know, 25-30% of patients with coronary artery disease have
persistent angina pectoris despite of PCI with or without optimal medical therapy

Product images
  • Ranolazine (Ranplaze 500)
Product sharing
Related products
Click + to add content

Company Address

No 20, 5th Floor , 8th Sharestan , Makoueipour St, Za'feraniyeh, Tehran-Iran

Phone: (+98) 21 26 80 5483 - 21 26 80 5489 - Fax: (+98)21 26 80 5478     Email: